| Year |
Citation |
Score |
| 2019 |
Chang C, Van Der Stegen S, Mili M, Clarke R, Lai Y, Witty A, Lindenbergh P, Yang B, Husain M, Shaked H, Groff B, Stokely L, Abujarour R, Lee T, Chu H, et al. FT819: Translation of Off-the-Shelf TCR-Less Trac-1XX CAR-T Cells in Support of First-of-Kind Phase I Clinical Trial Blood. 134: 4434-4434. DOI: 10.1182/Blood-2019-130584 |
0.399 |
|
| 2017 |
Zhu H, Lai YS, Li Y, Blum R, Kaufman D. Human Pluripotent Stem Cells to Produce Cell-based Cancer Immunotherapy. Stem Cells (Dayton, Ohio). PMID 29235195 DOI: 10.1002/stem.2754 |
0.39 |
|
| 2015 |
Chang CW, Lai YS, Westin E, Khodadadi-Jamayran A, Pawlik KM, Lamb LS, Goldman FD, Townes TM. Modeling Human Severe Combined Immunodeficiency and Correction by CRISPR/Cas9-Enhanced Gene Targeting. Cell Reports. 12: 1668-77. PMID 26321643 DOI: 10.1016/J.Celrep.2015.08.013 |
0.544 |
|
| 2014 |
Chang CW, Lai YS, Lamb LS, Townes TM. Broad T-cell receptor repertoire in T-lymphocytes derived from human induced pluripotent stem cells. Plos One. 9: e97335. PMID 24828440 DOI: 10.1371/Journal.Pone.0097335 |
0.538 |
|
| 2012 |
Lai YS, Chang CW, Pawlik KM, Zhou D, Renfrow MB, Townes TM. SRY (sex determining region Y)-box2 (Sox2)/poly ADP-ribose polymerase 1 (Parp1) complexes regulate pluripotency. Proceedings of the National Academy of Sciences of the United States of America. 109: 3772-7. PMID 22362888 DOI: 10.1073/Pnas.1108595109 |
0.49 |
|
| 2009 |
Chang CW, Lai YS, Pawlik KM, Liu K, Sun CW, Li C, Schoeb TR, Townes TM. Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells. Stem Cells (Dayton, Ohio). 27: 1042-9. PMID 19415770 DOI: 10.1002/Stem.39 |
0.529 |
|
| Show low-probability matches. |